Journal
CHEMMEDCHEM
Volume 7, Issue 7, Pages 1146-1159Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201200057
Keywords
drug discovery; fluorescent probes; inhibitor screening; proteases; proteomics
Categories
Funding
- Deutsche Forschungsgemeinschaft
- Center for Integrated Protein Science Munich (CIPSM)
- Fonds der Chemischen Industrie
Ask authors/readers for more resources
Proteases are important targets for the treatment of human disease. Several protease inhibitors have failed in clinical trials due to a lack of in vivo specificity, indicating the need for studies of protease function and inhibition in complex, disease-related models. The tight post-translational regulation of protease activity complicates protease analysis by traditional proteomics methods. Activity-based protein profiling is a powerful technique that can resolve this issue. It uses small-molecule toolsactivity-based probesto label and analyze active enzymes in lysates, cells, and whole animals. Over the last twelve years, a wide variety of protease activity-based probes have been developed. These synthetic efforts have enabled techniques ranging from real-time in vivo imaging of protease activity to high-throughput screening of uncharacterized proteases. This Review introduces the general principles of activity-based protein profiling and describes the recent advancements in probe design and analysis techniques, which have increased the knowledge of protease biology and will aid future protease drug discovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available